Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Alterity Therapeutics Ltd. reaffirms its commitment to high standards of corporate governance in line with the ASX Corporate Governance Council’s recommendations. The company’s latest Corporate Governance Statement details its robust framework for management, oversight, and ethical conduct, including performance reviews for the Board and executives, and emphasizes its dedication to diversity, despite not setting specific gender diversity objectives due to the small size of its workforce. Key governance documents are accessible on the company’s website, reflecting transparency and accountability to shareholders.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.
